Loading
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Latest filing published 07 Oct 2026 for AgomAb Therapeutics NV, €23k. Read the official filing
Filing timeline
BuySalePierre Thadee Victor Kemula
Insider track record
Disclosed buys
3
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
3
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Pierre Thadee Victor Kemula: trading record in brief
Pierre Thadee Victor Kemula is a declared insider of AgomAb Therapeutics NV, with filings sourced from SEC (Form 4). We count 3 filings, every one of them for a trade on 6 October 2026.
On the market, this insider has only ever bought: 3 purchases, €77k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The median purchase comes to €23k. Clusters matter here: 3 out of 3 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The newest entry dates from 7 October 2026: an open-market purchase of €23k, in AgomAb Therapeutics NV. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Pierre Thadee Victor Kemula
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
3,000 shares@ US$8.67Common sharesSEC:0002119332-26-000001:0
Canonical exit: 4 Jan 2027 (T+90)
5,000 shares@ US$8.57Common sharesSEC:0002119332-26-000001:1
Canonical exit: 4 Jan 2027 (T+90)
2,000 shares@ US$8.54Common sharesSEC:0002119332-26-000001:2
Canonical exit: 4 Jan 2027 (T+90)
3 of 3 declarations
